Search
for
Sort by
Research 361–390 of 1000+
- Abstracts
- Gene Array Profiling and Immunomodulation Studies Define a Cell-Mediated Immune Response Underlying the Pathogenesis of Alopecia Areata in a Mouse Model and Humans
- Anagen effluvium
- Risk Factors and Characterization of Vitiligo and Alopecia Areata in Patients With Chronic Graft-vs-Host Disease
- Madarosis, milphosis, eyelash trichomegaly, and dermatochalasis
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Hair loss in children.
- Burden of immune-related skin diseases worldwide, 1991–2021: insights and prediction from the Global Burden of Disease Study
- Thyroid Autoimmunity in Patients with Skin Disorders
- Role of topical tofacitinib in autoimmune skin disorders: An expert opinion
- The Evolving Global Burden of Alopecia Areata in Young Adults: High-Income Nations Bear the Greatest Impact
- Noval advance of histone modification in inflammatory skin diseases and related treatment methods
- Skin Diseases (Noncancerous)
- Induction of T cell exhaustion by JAK1/3 inhibition in the treatment of alopecia areata
- Alopecia Areata: Clinical Treatment
- Dermatologic Comorbidities Associated with Atopic Dermatitis Towards a Shared Therapeutical Approach: A Narrative Review
- Cardiodermatology: the heart of the connection between the skin and cardiovascular disease
- Isotretinoin and Hair Loss: A Clinical Perspective and Literature Review
- Successful Treatment of Hair Loss and Restoration of Natural Hair Color in Patient with Alopecia Areata Due to Psychological Disorder Using Exosomes: Case Report with 6-Month Follow-Up
- MOST IMPORTANT SKIN DISEASES OF CHILDRENTheir Diagnosis and Treatment
- Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
- Alopecia Areata: An Updated Review for 2023
- Simvastatin/Ezetimibe Therapy for Recalcitrant Alopecia Areata: An Open Prospective Study of 14 Patients
- Differential impact of environmental factors on systemic and localized autoimmunity
- British Hair and Nail Society
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- Janus Kinase inhibitors in dermatology: a review
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata